New data supports the idea that Merck’s Ebola vaccine Ervebo, licensed to target the Zaire species of ebolaviruses, could ...
A stepwise HIV vaccine strategy has induced broadly neutralizing antibodies in primates, hinting that a truly protective HIV ...
But politics could derail the one thing to unlock it.
Scientists have taken a major step toward developing an effective HIV vaccine after a new experimental vaccine successfully generated high levels of broadly ne ...
Add Yahoo as a preferred source to see more of our stories on Google. Moderna is developing an mRNA vaccine for the Bundibugyo virus driving the Ebola outbreak in the Democratic Republic of the Congo.
India has approved its first dengue vaccine, QDENGA, for people aged 4 to 60 years. Know who can receive it, how the two-dose ...
Qdenga, cleared this week for ages 4 to 60, is one of only a few dengue vaccines in the world. It is to be injected in two ...
A new HIV vaccine has generated powerful broadly neutralizing antibodies in animal studies and has now entered human trials, ...
Global health organisation CEPI will give roughly $60 million to Moderna and two other groups to accelerate the development of shots ​against Ebola Bundibugyo, the deadly virus that has swept through ...
Health and Human Services Secretary Robert F. Kennedy Jr. revealed his agency will be cutting funding to mRNA development, calling the vaccine technology "ineffective" and claiming it poses more risks ...